| http://www.w3.org/ns/prov#value | - Luminex President and CEO Patrick J. Balthrop commented on the approval in the release, saying the test has provided significant improvement to laboratories and health care systems in Europe and other countries and we are pleased to provide this important diagnostic to laboratories and patients in the United States. ... xTAG GPP has the potential to enable hospitals to improve patient outcomes wh
|
